 |
|
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
Li Xie, Hui Chen, Li Zhang, Yue Ma, Yuan Zhou, Yong-Yu Yang, Chang Liu, Yu-Li Wang, Ya-Jun Yan, Jia Ding, Xiao Teng, Qiang Yang, Xiu-Ping Liu, Jian Wu
Clin Mol Hepatol. 2024;30(2):206-224. Published online 2024 Jan 8 DOI: https://doi.org/10.3350/cmh.2023.0506
|
|
Citations to this article as recorded by
 JCAD deficiency delayed liver regenerative repair through the Hippo–YAP signalling pathway
Li Zhang, Yong‐Yu Yang, Li Xie, Yuan Zhou, Zhenxing Zhong, Jia Ding, Zhong‐Hua Wang, Yu‐Li Wang, Xiu‐Ping Liu, Fa‐Xing Yu, Jian Wu
Clinical and Translational Medicine.2024;[Epub] CrossRef JCAD, a new potential therapeutic target in cholestatic liver disease
Byoung Kuk Jang
Clinical and Molecular Hepatology.2024; 30(2): 166. CrossRef
|